The 57 references in paper Ia. Proletov Iu., E. Saganova S., A. Smirnov V., R. Zver'kov V., Я. Пролетов Ю., Е. Саганова С., А. Смирнов В., Р. Зверьков В. (2014) “БИОМАРКЕРЫ В ДИАГНОСТИКЕ ОСТРОГО ПОВРЕЖДЕНИЯ ПОЧЕК. СООБЩЕНИЕ II // BIOMARKERS IN THE DIAGNOSIS OF ACUTE KIDNEY INJURY. COMMUNICATION II” / spz:neicon:nefr:y:2014:i:6:p:51-58

1
Tolkoff-Rubin NE, Rubin RH, Bonventre JV. Noninvasive renal diagnostic studies. Clin Lab Med 1988; 8(3): 507–526.
(check this in PDF content)
2
Herget-Rosenthal S, Poppen D, Husing J et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004; 50(3): 552–8.
(check this in PDF content)
3
Emeigh Hart SG. Assessment of renal injury in vivo . J Pharmacol Toxicol Methods 2005; 52(1): 30-45.
(check this in PDF content)
4
Wolf MW, Boldt J. Kidney specific proteins: markers for detection of renal dysfunction after cardiac surgery? Clin Res Cardiol 2007; Suppl. 2: 103-107.
(check this in PDF content)
5
Penders J, Delanghe JR. Alpha 1-microglobulin: clinical laboratory aspects and applications. Clin Chim Acta 2004; 346(2): 107-118.
(check this in PDF content)
6
Bernard AM, Vyskocil AA, Mahieu P et al. Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin. Chem 1987; 33(6): 775–779.
(check this in PDF content)
7
Warning S, Moonie A. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury. Clinical Toxicology 2011; 49(8): 720–728.
(check this in PDF content)
8
D’Amico G, Bazzi C. Urinary protein and enzyme excretion as markers of tubular damage. Curr Opin Nephrol Hypertens 2003; 12 (6): 639–643.
(check this in PDF content)
9
Sushrut S. Waikar J. Bonventre V. Biomarkers for the Diagnosis of Acute Kidney Injury. Nephron Clin Pract 2008; 109(4): 192–197.
(check this in PDF content)
10
Westhuyzen J, Endre ZH, Reece G et al. Measurement of tubular enzymuria facilitates early detection of acute renal impairment in the intensive care unit. Nephrol Dial Transplan. 2003;18(3): 543–551.
(check this in PDF content)
11
Geus H, Betjes M, Bakker J. Biomarkers for the prediction of acute kidney injury: a narrative review on current status and future challenges. Clin Kidney J 2012; 5(2): 102-108.
(check this in PDF content)
12
Price RG. The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity. Clin Nephrol 1992; 38(1): 14-19.
(check this in PDF content)
13
Mukhopadhyay B, Chinchole S, Lobo V. et al. Enzymuria pattern in early port renal transplant period: diagnostic usefulness in graft dysfunction. Indian J Clin Biochem 2004; 19(2): 14-19.
(check this in PDF content)
14
Liangos O, Han WK, Wald R et al. Urinary kidney injurymolecule-1 (KIM-1) and N-acetyl (b)-D-glucosaminidase (NAG) levels in patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). J Am Soc Nephrol 2005; 16: 318A.
(check this in PDF content)
15
Vaidya VS,Waikar SS, FergusonMA, et al. Urinary biomarkers for sensitiveand specific detection of acute kidney injury in humans. Clin Transl Sci 2008; 1(3): 200–208.
(check this in PDF content)
16
Xu Z, Yang J, Yu J et al. Effects of BSO, GSH, Vit-Cand DMPS on the nephrotoxicity of mercury. Toxicol Ind Health 2007; 23(7): 403–410.
(check this in PDF content)
17
Ali BH, Al Moundhri MS, Tag Eldin M et al. The ameliorative effect of cysteine prodrug L-2-oxothiazolidine-4-carboxylic acid on cisplatin-induced nephrotoxicity in rats. FundamClin Pharmacol 2007; 21(5): 547–553.
(check this in PDF content)
18
Oktem F, Ozguner F, Sulak O et al. Lithium-induced renal toxicity in rats: protection by a novel antioxidant caffeic acid phenethyl ester. Mol Cell Biochem 2005; 277(1-2): 109–115.
(check this in PDF content)
19
Bondiou, M.T., Bourbouze, R., Bernard, M. et al. Inhibition ofAand B N-acetyl-beta-d-glucosaminidase urinary isoenzymes by urea. Clin Chim Acta 1985; 149(1): 67-73.
(check this in PDF content)
20
Iqbal MP, Ali AA, Waqar MA et al. Urinary Nacetyl-betad-glucosaminidase in rheumatoid arthritis. Exp Mol Med 1998; 30(3): 165-169.
(check this in PDF content)
21
Fujita H, Narita T, Morii T et al. Increased urinary excretion of N-acetylglucosaminidase in subjects with impaired glucose tolerance. Ren Fail 2002; 24(1): 69-75.
(check this in PDF content)
22
Tominaga M, Fujiyama, K, Hoshino T. et al. Urinary Nacetyl-beta-dglucosaminidase in the patients with hyperthyroidism. Horm Metab Res 1989; 21(8): 438-40.
(check this in PDF content)
23
Engel LS, Taioli E, Pfeiffer R et al. Pooled analysis and meta-analysis of glutathioneS-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002; 156(2): 95109.
(check this in PDF content)
24
Branten AJ, Mulder TP, Peters WH et al. Urinary excretion of glutathione-S-transferases alpha and pi in patients with proteinuria: reflection of the site of tubular injury. Nephron 2000; 85(2): 120-6.
(check this in PDF content)
25
Bruning T, Sundberg AG, Birner G et al. Glutathione transferase alpha as a marker for tubular damage after trichloroethylene exposure. Arch Toxicol 1999; 73(4-5): 246–254.
(check this in PDF content)
26
Bruning T, Thier R, Mann H et al. Pathological excretion patterns of urinary proteins in miners highly exposed to dinitrotoluene. J Occup Environ Med 2001; 43(7): 610–615.
(check this in PDF content)
27
Walshe CM, Odejayi F, Ng S et al. Urinary glutathione-Stransferase as an early marker for renal dysfunction in patients admitted to intensive care with sepsis. Crit Care Resusc 2009; 11(3): 204–209.
(check this in PDF content)
28
Santos C, Marcelino P, Carvalho T et al. The value of tubular enzymes for early detection of acute kidney injury after liver transplantation: an observational study. Transplant Proc 2010; 42(9): 3639–3643.
(check this in PDF content)
29
Whiting PH, Brown PA. . The relationship between enzymuria and kidney enzyme activities in experimental gentamicin nephrotoxicity. Ren Fail 1996; 18(6): 899–909.
(check this in PDF content)
30
Jenderny S, Lin H, Garrett T et al. Protective effects of a glutathione disulfi de mimetic (NOV-002) against cisplatin induced kidney toxicity. Biomed Pharmacother 2010; 64(1): 73–76.
(check this in PDF content)
31
Naghibi B, Ghafghazi T, Hajhashemi V et al. Vancomycininduced nephrotoxicity in rats: is enzyme elevation a consistent finding in tubular injury? J Nephrol 2007; 20(4): 482–488.
(check this in PDF content)
32
Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010; 11(9): 597-610.
(check this in PDF content)
33
2. Wessely O, Agrawal R, Tran U. MicroRNAs in kidney development: lessons from the frog. RNA Biol 2010; 7(3): 296-299.
(check this in PDF content)
34
Krupa A, Jenkins R, Luo DD e t al. MicroRNA-192 promotes fibrogenesis in diabetic nephropathy. J Am Soc Nephrol. 2010, 21(3), pp. 438-47.
(check this in PDF content)
35
Lee SO, Masyuk T, Splinter P et al. MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. J Clin Invest 2008; 118(11): 3714-24.
(check this in PDF content)
36
Xiong M, Jiang L, Zhou Y et al. The miR-200 family regulates TGF-b1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol 2012; 302(3): F369-379.
(check this in PDF content)
37
Godwin JG, Ge X, Stephan K. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci USA 2010; 107(32): 14339-14344.
(check this in PDF content)
38
Aguado-Fraile E, Ramos E, Sáenz-Morales D et al. miR127 protects proximal tubule cells against ischemia/reperfusion: identification of kinesin family member 3B as miR-127 target. PLoS One 2012; 7(9): e44305.
(check this in PDF content)
39
Liu F, Lou YL, Wu J et al. Upregulation of MicroRNA-210 regulates renal angiogenesis mediated by activation and in vitro. Kidney Blood Press Res 2012; 35(3): 182-91.
(check this in PDF content)
40
Lorenzen JM, Kielstein JT, Hafer C et al. Circulating miR210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 2011; 6(7): 1540-6.
(check this in PDF content)
41
Saikumar J, Hoffmann D, Kim TM et al. Expression, circulation and excretion profile of microRNA-21, -155, and -18a following acute kidney injury. Toxicol Sci 2012; 129(2): 256-267.
(check this in PDF content)
42
Lan YF, Chen HH, Lai PF et al. MicroRNA-494 reduces ATF3 expression and promotes AKI. J Am Soc Nephrol 2012; 23(12): 2012-2023.
(check this in PDF content)
43
Aguado-Fraile E, Ramos E, Conde E et al. microRNAs in the kidney: Novel biomarkers of Acute Kidney Injury. Nefrologia 2013; 33(6): 826-834.
(check this in PDF content)
44
Alge JL, Karakala N, Neely BA et al. Urinary angiotensinogen and risk of severe AKI. Clin J Am Soc Nephrol 2013; 8(2): 184-193.
(check this in PDF content)
45
Hu MC, Kuro-o M, Moe OW. The emerging role of Klotho in clinical nephrology. Nephrol Dial Transplant 2012; 27(7): 2650-7.
(check this in PDF content)
46
du Cheyron D, Daubin C, Poggioli J et al. Urinary measurement of Na+/H+ exchanger isoform 3 (NHE3) protein as new marker of tubule injury in critically ill patients with ARF. Am J Kidney Dis. 2003; 42(3): 497-506.
(check this in PDF content)
47
Zhou H, Yuen PS, Pisitkun T et al. Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery. Kidney Int 2006; 69(8): 1471-1476.
(check this in PDF content)
48
Zhou H, Pisitkun T, Aponte A et al. Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury. Kidney Int 2006; 70(10): 1847-1857.
(check this in PDF content)
49
Reeves WB, Kwon O, Ramesh G. Netrin-1 and kidney injury. II. Netrin-1 is an early biomarker of acute kidney injury. Am J Physiol Renal Physiol 2008; 294(4): 731-8.
(check this in PDF content)
50
Han WK, Wagener G, Zhu Y et al. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol 2009; 4(5): 873.
(check this in PDF content)
51
Nickolas TL, Schmidt-Ott KM, Canetta P et al. Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage: a multicenter prospective cohort study. J Am Coll Cardiol 2012; 59 (3): 246-255.
(check this in PDF content)
52
Endre ZH, Pickering JW, Walker RJ et al. Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal function. Kidney Int 2011; 79(10): 1119–1130.
(check this in PDF content)
53
Kokkoris S, Parisi M, Ioannidou S et al. Combination of renal biomarkers predicts acute kidney injury in critically ill adults. Ren Fail 2012; 34(9): 1100-1108.
(check this in PDF content)
54
Katagiri D, Doi K, Honda K et al. Combination of two urinary biomarkers predicts acute kidney injury after adult cardiac surgery. Ann Thorac Surg 2012; 93(2): 577-583.
(check this in PDF content)
55
Murugan R, Kellum JA. Acute kidney injury: what’s the prognosis? Nat Rev Nephrol 2011; 7 (4): 209-217.
(check this in PDF content)
56
Pickering JW, Endre ZH. Secondary prevention of acute kidney injury. Curr Opin Crit Care 2009; 15 (6): 488-497.
(check this in PDF content)
57
Bagshaw SM, Zappitelli M, Chawla LS. Novel biomarkers of AKI: the challenges of progress ‘Amid the noise and the haste’. Nephrol Dial Transplant 2013; 28(2): 235–238. Авторы заявляют об отсутствии конфликта интересов.
(check this in PDF content)